186 related articles for article (PubMed ID: 32526228)
21. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
[TBL] [Abstract][Full Text] [Related]
22. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CD44 is associated with the occurrence and migration of non-small cell lung cancer.
Li G; Gao Y; Cui Y; Zhang T; Cui R; Jiang Y; Shi J
Mol Med Rep; 2016 Oct; 14(4):3159-67. PubMed ID: 27573351
[TBL] [Abstract][Full Text] [Related]
24. Detection of circulating extracellular mRNAs by modified small-RNA-sequencing analysis.
Akat KM; Lee YA; Hurley A; Morozov P; Max KE; Brown M; Bogardus K; Sopeyin A; Hildner K; Diacovo TG; Neurath MF; Borggrefe M; Tuschl T
JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30973829
[TBL] [Abstract][Full Text] [Related]
25. Role of hemoglobin alpha and hemoglobin beta in non-small-cell lung cancer based on bioinformatics analysis.
Kang N; Qiu WJ; Wang B; Tang DF; Shen XY
Mol Carcinog; 2022 Jun; 61(6):587-602. PubMed ID: 35394695
[TBL] [Abstract][Full Text] [Related]
26. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
27. Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer.
Chen N; Li G; Li H; Xiang X; Guo G; Ma Q; Zhang Y
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):208-213. PubMed ID: 33040838
[TBL] [Abstract][Full Text] [Related]
28. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential tumor-educated platelets RNA biomarkers in non-small-cell lung cancer by integrated bioinformatical analysis.
Xue L; Xie L; Song X; Song X
J Clin Lab Anal; 2018 Sep; 32(7):e22450. PubMed ID: 29665143
[TBL] [Abstract][Full Text] [Related]
30. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
31. Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Lou TF; Sethuraman D; Dospoy P; Srivastva P; Kim HS; Kim J; Ma X; Chen PH; Huffman KE; Frink RE; Larsen JE; Lewis C; Um SW; Kim DH; Ahn JM; DeBerardinis RJ; White MA; Minna JD; Yoo H
Cancer Prev Res (Phila); 2016 Jan; 9(1):43-52. PubMed ID: 26511490
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC.
Chang JW; Shih CL; Wang CL; Luo JD; Wang CW; Hsieh JJ; Yu CJ; Chiou CC
Cancer Genomics Proteomics; 2020; 17(1):91-100. PubMed ID: 31882554
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer.
Hoang LT; Domingo-Sabugo C; Starren ES; Willis-Owen SAG; Morris-Rosendahl DJ; Nicholson AG; Cookson WOCM; Moffatt MF
Mol Oncol; 2019 Nov; 13(11):2406-2421. PubMed ID: 31461552
[TBL] [Abstract][Full Text] [Related]
34. Blood-based gene expression signatures in non-small cell lung cancer.
Zander T; Hofmann A; Staratschek-Jox A; Classen S; Debey-Pascher S; Maisel D; Ansén S; Hahn M; Beyer M; Thomas RK; Gathof B; Mauch C; Delank KS; Engel-Riedel W; Wichmann HE; Stoelben E; Schultze JL; Wolf J
Clin Cancer Res; 2011 May; 17(10):3360-7. PubMed ID: 21558400
[TBL] [Abstract][Full Text] [Related]
35. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Xiong Y; Feng Y; Qiao T; Han Y
Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
[TBL] [Abstract][Full Text] [Related]
36. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
37. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
38. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
40. Extracellular RNA in a single droplet of human serum reflects physiologic and disease states.
Zhou Z; Wu Q; Yan Z; Zheng H; Chen CJ; Liu Y; Qi Z; Calandrelli R; Chen Z; Chien S; Su HI; Zhong S
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19200-19208. PubMed ID: 31481608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
